Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.

Purpose: To evaluate the safety and efficacy of mitomycin-C (MMC) 0.01% (0.1 mg/mL) in preventing haze formation after wavefront-guided photorefractive keratectomy (PRK) for higher myopia at 3 exposures.

Acute vision loss: a fuzzy presentation of sarcoidosis.

Background: Acute vision loss is a devastating problem for patients and a challenging diagnostic dilemma for Emergency Physicians. This chief complaint is one in which we must be adept at quickly evaluating and initiating either care or referral.

Objectives: This case reviews the approach to acute vision loss and shows the importance of expanding the differential in atypical and complex presentations.